HCA Healthcare, Inc. $HCA Shares Purchased by Savant Capital LLC

Savant Capital LLC boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 37.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,548 shares of the company’s stock after buying an additional 1,246 shares during the quarter. Savant Capital LLC’s holdings in HCA Healthcare were worth $1,938,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Sovran Advisors LLC grew its stake in shares of HCA Healthcare by 1.0% during the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after purchasing an additional 22 shares in the last quarter. Hemington Wealth Management boosted its position in shares of HCA Healthcare by 11.0% during the 3rd quarter. Hemington Wealth Management now owns 253 shares of the company’s stock worth $107,000 after acquiring an additional 25 shares in the last quarter. Abound Wealth Management lifted its stake in HCA Healthcare by 28.0% during the third quarter. Abound Wealth Management now owns 119 shares of the company’s stock worth $51,000 after purchasing an additional 26 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC increased its stake in HCA Healthcare by 17.1% in the third quarter. Annis Gardner Whiting Capital Advisors LLC now owns 185 shares of the company’s stock valued at $79,000 after purchasing an additional 27 shares during the last quarter. Finally, Ballentine Partners LLC boosted its holdings in shares of HCA Healthcare by 0.8% in the 3rd quarter. Ballentine Partners LLC now owns 3,693 shares of the company’s stock valued at $1,574,000 after buying an additional 29 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 2.3%

Shares of NYSE:HCA opened at $501.89 on Monday. The company has a market cap of $114.53 billion, a price-to-earnings ratio of 17.68, a PEG ratio of 1.54 and a beta of 1.36. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $527.55. The firm’s 50-day simple moving average is $479.97 and its 200-day simple moving average is $443.35.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a dividend of $0.78 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 10.15%.

Insiders Place Their Bets

In other news, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. This trade represents a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of several research analyst reports. Truist Financial upped their price objective on shares of HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Royal Bank Of Canada lifted their price target on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Argus raised their target price on shares of HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a research report on Friday. KeyCorp set a $503.00 price target on shares of HCA Healthcare in a research note on Wednesday, January 28th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $521.55.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.